Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

The lack of effective treatment modalities is a major problem in pancreatic cancer (PCa), a devastating malignancy that is nearly universally driven by the “undruggable” KRAS and TP53 cancer genes. Poor tumor tissue penetration is the major source of resistance in pancreatic cancer where chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobrov, Egor, Skobeleva, Natalia, Restifo, Diana, Beglyarova, Natalya, Cai, Kathy Q., Handorf, Elizabeth, Campbell, Kerry, Proia, David A., Khazak, Vladimir, Golemis, Erica A., Astsaturov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354841/
https://www.ncbi.nlm.nih.gov/pubmed/27779106
http://dx.doi.org/10.18632/oncotarget.12642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354841/
https://www.ncbi.nlm.nih.gov/pubmed/27779106
http://dx.doi.org/10.18632/oncotarget.12642

Ejemplares similares